Human Hindbrain Organoid Functional Assay Services.
Key Takeaways
- Set-aside for No Set Aside businesses
- Work to be performed in Rockville, MD
- Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Contract Details
- Notice ID
- RFQ_CDR-2026-135968
- Opportunity Type
- Combined Synopsis/Solicitation
- Sub-Agency
- FOOD AND DRUG ADMINISTRATION
- Office
- FDA OFFICE OF ACQ GRANT SVCS
- Posted Date
- Friday, September 11, 2026
- Response Deadline
- Thursday, September 17, 2026
- PSC Code
- B504
- Set-Aside
- No Set Aside
- Place of Performance
- Rockville, MD, 20852
- Status
- Active
Description
The U.S. Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Division of Applied Regulatory Science (DARS), intends to award a sole-source, Firm-Fixed-Price purchase order to OrganoTherapeutics SARL for Human iPSC-Derived Hindbrain Organoid Functional Assay Services. The requirement includes the provision of human induced pluripotent stem cell (iPSC)-derived hindbrain organoids and associated materials necessary to support in vitro research evaluating drug-induced effects on respiratory-relevant neural circuits. The contractor will also perform functional characterization of the organoids using three-dimensional multi-electrode array (3D MEA) technology to assess electrophysiological responses to drugs known to affect respiratory function. The functional cha
Why This Opportunity Matters
HEALTH AND HUMAN SERVICES, DEPARTMENT OF is actively seeking qualified contractors for research and development in biotechnology (except nanobiotechnology) with a set-aside for No Set Aside businesses in Rockville, MD. This set-aside designation means eligible businesses face reduced competition from larger firms.
Similar Opportunities
Browse Related
Looking for more opportunities?
Browse our full directory of government contracts
